Zions Bancorporation’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $68.9K | Hold |
171
| – | – | ﹤0.01% | 398 |
|
2024
Q3 | $79.5K | Sell |
171
-45
| -21% | -$20.9K | 0.01% | 396 |
|
2024
Q2 | $101K | Sell |
216
-83
| -28% | -$38.9K | 0.01% | 381 |
|
2024
Q1 | $125K | Sell |
299
-707
| -70% | -$296K | 0.01% | 349 |
|
2023
Q4 | $409K | Sell |
1,006
-143
| -12% | -$58.2K | 0.03% | 264 |
|
2023
Q3 | $400K | Sell |
1,149
-24
| -2% | -$8.35K | 0.04% | 256 |
|
2023
Q2 | $413K | Sell |
1,173
-11
| -0.9% | -$3.87K | 0.03% | 261 |
|
2023
Q1 | $373K | Buy |
1,184
+368
| +45% | +$116K | 0.03% | 262 |
|
2022
Q4 | $236K | Buy |
816
+65
| +9% | +$18.8K | 0.02% | 303 |
|
2022
Q3 | $217K | Sell |
751
-2
| -0.3% | -$578 | 0.02% | 299 |
|
2022
Q2 | $212K | Buy |
753
+37
| +5% | +$10.4K | 0.02% | 308 |
|
2022
Q1 | $187K | Buy |
716
+420
| +142% | +$110K | 0.02% | 329 |
|
2021
Q4 | $65K | Sell |
296
-55
| -16% | -$12.1K | 0.01% | 429 |
|
2021
Q3 | $64K | Sell |
351
-153
| -30% | -$27.9K | 0.01% | 424 |
|
2021
Q2 | $102K | Buy |
504
+178
| +55% | +$36K | 0.01% | 352 |
|
2021
Q1 | $70K | Sell |
326
-22
| -6% | -$4.72K | 0.01% | 377 |
|
2020
Q4 | $82K | Sell |
348
-10
| -3% | -$2.36K | 0.01% | 335 |
|
2020
Q3 | $97K | Buy |
358
+61
| +21% | +$16.5K | 0.01% | 293 |
|
2020
Q2 | $86K | Sell |
297
-15
| -5% | -$4.34K | 0.01% | 289 |
|
2020
Q1 | $74K | Sell |
312
-77
| -20% | -$18.3K | 0.01% | 284 |
|
2019
Q4 | $85K | Sell |
389
-18
| -4% | -$3.93K | 0.01% | 335 |
|
2019
Q3 | $69K | Hold |
407
| – | – | 0.01% | 374 |
|
2019
Q2 | $75K | Sell |
407
-45
| -10% | -$8.29K | 0.01% | 338 |
|
2019
Q1 | $83K | Sell |
452
-4
| -0.9% | -$735 | 0.01% | 332 |
|
2018
Q4 | $76K | Sell |
456
-7
| -2% | -$1.17K | 0.06% | 140 |
|
2018
Q3 | $89K | Buy |
463
+24
| +5% | +$4.61K | 0.02% | 254 |
|
2018
Q2 | $75K | Buy |
+439
| New | +$75K | 0.05% | 140 |
|
2018
Q1 | – | Sell |
-446
| Closed | -$67K | – | 701 |
|
2017
Q4 | $67K | Buy |
446
+22
| +5% | +$3.31K | 0.01% | 307 |
|
2017
Q3 | $64K | Buy |
424
+367
| +644% | +$55.4K | 0.01% | 517 |
|
2017
Q2 | $7K | Sell |
57
-69
| -55% | -$8.47K | ﹤0.01% | 395 |
|
2017
Q1 | $15K | Sell |
126
-148
| -54% | -$17.6K | ﹤0.01% | 318 |
|
2016
Q4 | $20K | Buy |
274
+42
| +18% | +$3.07K | ﹤0.01% | 383 |
|
2016
Q3 | $17K | Buy |
232
+40
| +21% | +$2.93K | ﹤0.01% | 407 |
|
2016
Q2 | $17K | Buy |
192
+12
| +7% | +$1.06K | ﹤0.01% | 367 |
|
2016
Q1 | $16K | Buy |
180
+34
| +23% | +$3.02K | ﹤0.01% | 440 |
|
2015
Q4 | $13K | Sell |
146
-22
| -13% | -$1.96K | ﹤0.01% | 445 |
|
2015
Q3 | $20K | Buy |
+168
| New | +$20K | ﹤0.01% | 358 |
|
2015
Q2 | – | Sell |
-163
| Closed | -$19K | – | 727 |
|
2015
Q1 | $19K | Buy |
+163
| New | +$19K | ﹤0.01% | 393 |
|